2022 annual financial data

Neumora Therapeutics, Inc. 2022 Financial results

Neumora Therapeutics, Inc. 2022 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -135,870,000 USD and net income was -130,904,000 USD.
Operating cash flow was -114,896,000 USD.

Get free Neumora Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-135,870,000 USD
Net income
-130,904,000 USD
Operating cash flow
-114,896,000 USD